Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

35.74
Delayed Data
As of Feb 12
 +1.49 / +4.35%
Today’s Change
30.93
Today|||52-Week Range
77.80
-42.29%
Year-to-Date

Today’s Trading

Previous close34.25
Today’s open34.86
Day’s range33.24 - 35.84
Volume2,801,121
Average volume (3 months)1,718,951
Market cap$4.3B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-100.23%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+45.41%
P/E ratio299.9
Price/Sales33.93
Price/Book16.42

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+0.74+1.12%
ALNYAlnylam Pharmaceutic...+2.59+4.55%
CRLCharles River Labora...+1.26+1.78%
PRXLPAREXEL Internationa...+0.04+0.07%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateFebruary 26, 2016
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$214.2M
Annual profit (last year)-$39.0M
Net profit margin-18.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts

Partner Offers